This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Subepithelial Tumors of the Upper Gastrointestinal Tract
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The goal of this prospective study is to evaluate the feasibility of the 22-G Core Biopsy Needle with reverse bevel (Procore TM) in biopsy sampling of subepithelial tumors of the upper gastrointestinal tract.

Provided treatments

  • Device: 22-G Procore Needle

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01726010. The sponsor of the trial is Technische Universität München and it is looking for 20 volunteers for the current phase.
Official trial title:
Endoscopic Ultrasound Guided Biopsy of Subepithelial Tumors of the Upper Gastrointestinal Tract Using the 22-G-Procore Needle